Clinical trial
Endogenous Opioid Modulation by Ketamine
NCT03051945 is registered in ClinicalTrials.gov with University of Utah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endogenous Opioid Modulation by Ketamine
- Lead sponsor
- University of Utah
- Phase
- Phase 3
- Overall status
- Withdrawn
- Start date
- August 31, 2019
- Completion date
- August 1, 2019
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.